Bivalirudin vs. Heparin for Patients Undergoing PCI after STEMI (IMAGE)
Caption
Reduction in the risk of death or major bleeding after primary PCI in patients with STEMI treated with heparin monotherapy (blue curve) or bivalirudin with a post-procedure infusion (red curve). The hazard ratio of 0.69 signifies a 31% reduction in risk. The ARR (absolute risk reduction) was 1.3%. The NNT (number of patients needed to treat to prevent one death or large bleed) was 76.
Credit
Mount Sinai Health System
Usage Restrictions
with credit
License
Original content